Page last updated: 2024-12-11

fce 20700

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID6439868
MeSH IDM0121323

Synonyms (9)

Synonym
fce-20700
11-deoxy-13,14-didehydro-16(s)-methylprostaglandin e2 methyl ester
fce 20700
(5z,15s,16s)-15-hydroxy-16-methyl-9-oxoprost-5-en-13-yn-1-oic acid methyl ester
prost-5-en-13-yn-1-oic acid, 15-hydroxy-16-methyl-9-oxo-, methyl ester, (5z,15s,16s)-
methyl (z)-7-[(1r,2s)-2-[(3s,4s)-3-hydroxy-4-methyloct-1-ynyl]-5-oxocyclopentyl]hept-5-enoate
89648-76-0
11-deoxy-13,14-didehydro-16-methyl-pge2 methyl ester
DTXSID401034109

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" FCE 20700 (5 micrograms/ml, sc) did not change, by itself, either SGPT or diazepam pharmacokinetic parameters, but significantly antagonized the changes induced by CC14 (SGPT: 45."( Carbon tetrachloride-induced pharmacokinetic changes of diazepam in rats are reduced by a stable analogue of prostaglandin E2 : FCE 20700.
Ceserani, R; Costa, G; Padovano, I; Puzzolo, D; Saija, A, 1985
)
1.38

Dosage Studied

ExcerptRelevanceReference
" The dose-response relationship in preventing gastric mucosal damage and in inhibiting gastric acid and pepsin secretion was investigated."( Protective and antisecretory effects of the new PGE2 analogue, FCE 20700, and of 16,16 dimethyl PGE2 in pylorus-ligated rat.
Barocelli, E; Chiavarini, M; Impicciatore, M; Morini, G, 1988
)
0.51
" dosing the effect of the compound on pentagastrin-stimulated AS and on mucoproteins and bicarbonate content in the gastric juice was measured."( Effects of FCE20700, a new PGE2 derivative, on gastric acid secretion and cytoprotective processes in man.
Barbieri, C; Caldara, R; Cantù, A; Carbone, M; Dubini, A; Ferrari, C; Guslandi, M; Masci, E, 1987
)
0.27
" Moreover the gastric lesions in FCE 20700 + I treated rats were markedly reduced, allowing the dosage of I to be increased by about three times without increasing its ulcerogenic effect."( FCE 20700, a cytoprotective PGE2 derivative, does not interfere with the antiinflammatory activity of indomethacin.
Arrigoni, C; Buttinoni, A; Ceserani, R; Ferrari, M; Mizzotti, B; Tremolada, L, 1983
)
1.99
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.05 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (25.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (75.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]